Table 1 Clinical determinants and outcome of bloodstream infections in older persons

Male

470 (60.3%)

410 (50.5%)

209 (56.5%)

Hospital-onset

Healthcare-associated

Community-associated

139 (17.8%)

377 (48.2%)

267 (34.1%)

121 (17.3%)

374 (53.4%)

206 (29.4%)

58 (15.7%)

220 (59.5%)

92 (24.9%)

Median (interquartile range) Charlson Comorbidity Index

2 (1–4)

2 (1–4)

2 (1–3)

Co-morbidity

Myocardial infarction

Congestive heart failure

Peripheral vascular disease

Stroke

Plegia

Chronic lung disease

Diabetes mellitus

Renal disease

Liver disease

Cancer

Dementia

Rheumatic disease

HIV/AIDS

88 (11.2%)

65 (8.3%)

76 (9.7%)

59 (7.5%)

26 (3.3%)

163 (20.8%)

239 (30.5%)

90 (11.5%)

73 (9.3%)

229 (29.3%)

29 (3.7%)

58 (6.1%)

1 (0.1%)

87 (12.4%)

113 (16.1%)

67 (9.6%)

79 (11.3%)

18 (2.6%)

152 (21.7%)

213 (30.4%)

95 (13.6%)

21 (3.0%)

209 (29.8%)

104 (14.8%)

31 (4.4%)

0

54 (14.6%)

85 (23.0%)

26 (7.0%)

53 (14.3%)

13 (3.5%)

82 (22.2%)

74 (20.0%)

57 (15.4%)

4 (1.1%)

98 (26.5%)

95 (25.7%)

17 (4.6%)

0

Microbiology group

Gram-positive

Gram-negative

Anaerobes

Yeast

Polymicrobial

308 (39.3%)

376 (48.0%)

33 (4.2%)

12 (1.5%)

54 (6.9%)

261 (37.2%)

359 (51.2%)

26 (3.7%)

5 (0.7%)

50 (7.1%)

114 (30.8%)

213 (57.6%)

15 (4.1%)

2 (0.54%)

26 (7.0%)

Clinical focus

No focus

Bone and joint

Soft tissue

Respiratory

Cardiovascular

Abdomen/pelvic

Central nervous

Genitourinary

121 (15.5%)

60 (7.7%)

76 (9.7)

84 (10.7%)

49 (6.3%)

161 (20.6%)

3 (0.4%)

229 (29.3%)

107 (15.3%)

37 (5.3%)

54 (7.7%)

74 (10.6%)

45 (6.4%)

147 (21.0%)

1 (0.1%)

236 (33.7%)

51 (13.8%)

14 (3.8%)

18 (4.9%)

48 (13.0%)

26 (7.0%)

68 (18.4%)

0

145 (39.2%)

Admitted to hospital

717 (91.6%)

645 (92.0%)

347 (93.8%)

Median length of stay in days (IQR)

All patients

Survivors to discharge

10 (5–24)

9 (5–21)

9 (4–19)

9 (5–19)

8 (5–18)

9 (5–20)

Day 30 case-fatality

138 (17.6%)

167 (23.8%)

101 (27.3%)